Veltro Argento — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

Fractylfractyl.com in 𝕏NASDAQ: GUTSJun 2021SEC filingmedium confidence

Fractyl develops therapies for obesity and type 2 diabetes, focusing on non-drug-based approaches rooted in understanding metabolic disease mechanisms.

BiotechHealthtechMedical DevicesLexington, US

HARITH RAJAGOPALAN(Executive Officer, Director)JAY CAPLAN(Executive Officer, Director)Harith Rajagopalan(Executive Officer, Director)inLISA DAVIDSON(Executive Officer)Ajay Royan(Director)Christopher Gabrieli(Director)

Board seatMarc Elia· per SEC Form D · $100M raise · filed Jun 2021

Co-investorsBessemer Venture Partners Catalio Capital Management, LP Emergent Medical Partners, LLP Mithril Capital Management Polaris Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.